Search - tctmd.com

Displaying 1 - 20 of 348

Sort: Relevancy | Date

News Conference News VIVA 2026

PROMISE III: Deep Vein Arterialization Reduces Pain at 1 Year

L.A. McKeown

October 12, 2026

News Conference News VIVA 2026

VIVA 2026: What to Expect in Las Vegas

L.A. McKeown

October 05, 2026

News Daily News

BEST-CLI Cost Analysis Favors Surgery Over Endovascular Therapy

L.A. McKeown

August 10, 2026

News Daily News

Lp(a) Levels Interplay With Sex Hormones to Influence VTE Risk

Yael L. Maxwell

July 30, 2026

News Daily News

PERT Consortium Gives Snapshot of Recent PE Care in the US

Todd Neale

June 12, 2026

News Conference News SCAI 2026

No-Option CLTI Patients Report Better QoL After Blood Flow Diversion Therapy: PROMISE III

L.A. McKeown

April 24, 2026

News Conference News SIR 2026

C-TRACT: Iliac Vein Stenting Results Look Good in Postthrombotic Syndrome

L.A. McKeown

April 14, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2026

Caitlin E. Cox

April 01, 2026

News Conference News ACC 2026

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

L.A. McKeown

March 28, 2026

News Daily News

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

Yael L. Maxwell

March 16, 2026

News Daily News

Many PE Teams Embraced Mechanical Thrombectomy Early On: PERT Registry

L.A. McKeown

March 06, 2026

News Daily News

AHA/ACC Guideline Tackles Evidence-Based Acute PE Care

L.A. McKeown

February 19, 2026

News Conference News EAPCI 2026

Pulmonary Embolism: Studies Chart Gaps in Care but Also Progress

Caitlin E. Cox

February 19, 2026

News Daily News

Public Reporting Tied to Better Care, but Similar Outcomes, in Stroke Centers

Todd Neale

January 16, 2026

News Daily News

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Caitlin E. Cox

January 08, 2026

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

Presentation ACC 2025

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Presenter: Isabelle Mahé

March 29, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

Advertisement

PROMISE III: Deep Vein Arterialization Reduces Pain at 1 Year

VIVA 2026: What to Expect in Las Vegas

BEST-CLI Cost Analysis Favors Surgery Over Endovascular Therapy

Lp(a) Levels Interplay With Sex Hormones to Influence VTE Risk

PERT Consortium Gives Snapshot of Recent PE Care in the US

No-Option CLTI Patients Report Better QoL After Blood Flow Diversion Therapy: PROMISE III

C-TRACT: Iliac Vein Stenting Results Look Good in Postthrombotic Syndrome

TCTMD’s Top 10 Most Popular Stories for March 2026

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

Many PE Teams Embraced Mechanical Thrombectomy Early On: PERT Registry

AHA/ACC Guideline Tackles Evidence-Based Acute PE Care

Pulmonary Embolism: Studies Chart Gaps in Care but Also Progress

Public Reporting Tied to Better Care, but Similar Outcomes, in Stroke Centers

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

What’s Going to Be Hot at ACC 2025?

Top Endovascular News of 2024

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content